Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1136
| Despition | TYRO3 Blocking Peptide for Immunocompeition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1293 | TORC2 Blocking Peptide (AC1293) | 250 µg | inquiry |
| ACPP-1618 | Human SYT11 Protein (AC1618) | 2 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1663 | Human DUSP6 Protein (AC1663) | 2 µg | inquiry |
| ACPP-1124 | Recombinant Human MAP2C Protein (AC1124) | 25 µl | inquiry |
| ACPP-1729 | Human OCM Protein (AC1729) | 2 µg | inquiry |
| ACPP-1304 | Netrin 1 Blocking Peptide (AC1304) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.